“Women with the same medical condition as men are less likely to be offered treatment such as surgery, a stent or a strong painkiller”

• Cardiac care: multiple large registry studies and professional-society reviews find women with acute coronary syndromes are less likely than men to receive timely angiography, revascularisation (stenting/bypass) and guideline-recommended drug therapy. The American Heart Association's 2016 scientific statement 'Acute Myocardial Infarction in Women' explicitly documents that women are less likely to receive reperfusion/invasive management and evidence-based therapies, and the 2021 Lancet Women and Cardiovascular Disease Commission reports the same undertreatment pattern globally.
• Pain management: Chen et al. (Academic Emergency Medicine, 2008) studied ED patients presenting with acute abdominal pain and found women were significantly less likely than men to receive any analgesia and less likely to receive opioids, and waited longer for medication, despite reporting similar pain scores.
• Surgery/orthopaedics: Borkhoff et al. (CMAJ, 2008) used identical standardised patients differing only in sex; physicians were roughly 22 times more likely to recommend total knee arthroplasty to the male than the female patient — a controlled design that isolates sex as the variable and supports a causal (not just confounded) reading of the claim.
• Utilisation gap: Hawker et al. (NEJM, 2000) found that, after accounting for the higher underlying prevalence and severity of arthritis in women, the rate of hip and knee arthroplasty use was substantially lower in women relative to need — i.e. women with the same or worse disease were less likely to be operated on.
• Young MI patients: the VIRGO study (Lichtman et al., Circulation, 2018) found young women with myocardial infarction were more likely to have their symptoms attributed to non-cardiac causes by clinicians, a mechanism that leads downstream to fewer invasive treatments.
• Policy recognition: the UK Government's Women's Health Strategy for England (2022), built on a 100,000-response call for evidence, states that women's pain is too often dismissed and that women face worse access to diagnosis and treatment — government endorsement that the phenomenon is real, not merely anecdotal.

• The claim is a sweeping generalisation. The evidence base is condition-specific (cardiology, orthopaedics, emergency analgesia, transplantation, some cancers); it is not established that women are undertreated for every condition, and for some interventions and drug classes women receive equal or more treatment.
• Counter-examples exist: women in the US and UK receive more primary care contacts and more prescription medicines overall, including more long-term opioid analgesic prescriptions in some national datasets — so 'less likely to be offered a strong painkiller' does not hold universally across settings.
• Confounding: much of the cardiac evidence is observational. Women with MI are on average about a decade older, present later, have more comorbidities and more non-obstructive coronary disease (MINOCA) — for which a stent is not the indicated treatment. Part of the raw treatment gap is clinically appropriate rather than bias, and some adjusted analyses find much smaller or non-significant differences.
• Effect sizes vary enormously and some headline figures (e.g. the 22-fold knee-replacement result) come from small standardised-patient experiments that may not generalise to real-world practice at that magnitude.
• Trend data suggest gaps have narrowed over time in several health systems as guidelines and quality indicators have been introduced, so present-tense blanket statements overstate the current gap in some countries.
• The claim as phrased implies physician bias as the cause; patient-side factors (women more often declining surgery, differing symptom reporting, later presentation) also contribute to measured differences in who is treated.

82/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Canadian Medical Association Journal (Borkhoff et al., 2008)journal · 92 · New England Journal of Medicine (Hawker et al., 2000)journal · 96 · Academic Emergency Medicine (Chen et al., 2008)journal · 87 · Circulation / American Heart Association scientific statement (Mehta et al., 2016)journal · 94 · The Lancet women and cardiovascular disease Commission (2021)journal · 95 · Circulation / VIRGO study (Lichtman et al., 2018)journal · 93 · UK Department of Health and Social Caregov · 88

• Cardiac/stent-like care: The American Heart Association scientific statement on acute myocardial infarction in women reports that women with STEMI/ACS have been less likely than men to receive guideline-recommended reperfusion and invasive care, including coronary angiography and PCI, even though these are standard treatments for the same acute coronary syndromes.
• Older but direct coronary-disease evidence: Ayanian and Epstein in NEJM found women hospitalized with coronary heart disease underwent fewer major cardiac procedures than men, including coronary angiography, angioplasty and bypass surgery, after accounting for clinical factors.
• Surgery: In a standardized-patient study of knee osteoarthritis, physicians were significantly less likely to recommend total knee arthroplasty for a female patient than for an otherwise similar male patient, which directly supports the 'offered surgery' part of the claim in at least one condition.
• Surgery utilization: A population study in NEJM found lower use of hip/knee arthroplasty among women despite need, consistent with underuse of surgery in women with comparable joint disease.
• Strong painkiller: In an Academic Emergency Medicine study of emergency-department patients with acute abdominal pain, women were less likely than men to receive any analgesic and less likely to receive opioids, and waited longer for analgesia.

• The wording is broad. The evidence is strongest for particular settings—acute coronary syndromes, joint replacement, and emergency abdominal pain—not for every medical condition or every treatment.
• Many studies measure treatment received, not the exact moment of being 'offered' treatment. Some sex gaps may be partly explained by age, comorbidities, contraindications, symptom presentation, patient preferences, or delays in presentation rather than clinician refusal alone.
• The painkiller example is not universal: CDC/NCHS data show women overall reported higher recent prescription-opioid use than men in U.S. population data, so the ED abdominal-pain finding should not be generalized to all pain conditions or prescribing contexts.
• Cardiac-care gaps have narrowed over time in some systems and are not identical across countries, hospitals, and subgroups. The claim is best read as describing a well-documented pattern, not an invariant rule.

84/100 — the lab’s own confidence in the score above, not a second reading of the claim.

American Heart Association/Circulationjournal · 95 · New England Journal of Medicinejournal · 94 · Canadian Medical Association Journal via PubMedjournal · 90 · New England Journal of Medicinejournal · 94 · Academic Emergency Medicine via PubMedjournal · 90 · CDC/National Center for Health Statisticsgov · 95

• Extensive peer-reviewed literature in cardiology demonstrates that women presenting with acute myocardial infarction (heart attacks) are statistically less likely than men to receive guideline-directed medical therapies, timely coronary angiography, or percutaneous coronary interventions (stents), despite having similar or higher risk profiles.
• Studies on emergency medicine and pain management consistently show a gender disparity in the treatment of acute pain. Women reporting equivalent pain scores to men are significantly less likely to receive strong analgesics (such as opioids), experience longer wait times for pain relief, and are more frequently prescribed sedatives or psychotropic drugs instead.
• Orthopedic and surgical research indicates that women are systematically under-referred for joint replacement surgeries. For example, women with severe osteoarthritis are significantly less likely to be offered total knee or hip arthroplasty compared to men with identical objective clinical indications.

• Some of the statistical disparity in specific treatments, such as stents, is partially explained by physiological differences rather than implicit bias alone. Women are more likely to experience myocardial infarctions with non-obstructive coronary arteries (MINOCA) or microvascular dysfunction, where stents are not the clinically indicated treatment.
• In highly standardized, protocol-driven emergency departments, some recent studies show that the gender gaps in immediate treatment times (such as 'door-to-balloon' time for severe heart attacks) and pain management have narrowed considerably or disappeared.

95/100 — the lab’s own confidence in the score above, not a second reading of the claim.

American Heart Association (Circulation)journal · 95 · New England Journal of Medicinejournal · 95 · Harvard Health Publishingedu · 90

• A 2026 systematic review from the University of St Andrews reported that, among 38 studies using patient records, 33 found a statistically significant difference in treatment between male and female patients. The review’s reported examples included surgery, stents, and strong painkillers. This directly supports the claim, although the review’s scope and methods should be checked in the underlying journal article. [https://news.st-andrews.ac.uk/archive/women-less-likely-than-men-to-be-offered-active-medical-treatment-for-the-same-conditions/](https://news.st-andrews.ac.uk/archive/women-less-likely-than-men-to-be-offered-active-medical-treatment-for-the-same-conditions/)
• A peer-reviewed emergency-department study found that women with acute abdominal pain were less likely than men to receive any analgesia (60% versus 67%) or opiates (45% versus 56%). After adjustment for age, race, triage category, and pain score, women remained 13%–25% less likely to receive opioid analgesia. [https://onlinelibrary.wiley.com/doi/full/10.1111/j.1553-2712.2008.00100.x](https://onlinelibrary.wiley.com/doi/full/10.1111/j.1553-2712.2008.00100.x)
• A 2024 study reported that women in emergency departments received pain medication less often than men with comparable reported pain: 38% versus 47%. The disparity remained after accounting for pain ratings and was observed for both opioid and non-opioid medication. [https://www.pnas.org/doi/pdf/10.1073/pnas.2401331121](https://www.pnas.org/doi/pdf/10.1073/pnas.2401331121)
• For STEMI heart attacks, a study reported that women were 34% less likely than men to receive procedures to clear blocked arteries, including bypass surgery and stents. [https://www.bbc.com/news/health-42590013](https://www.bbc.com/news/health-42590013)
• The American Heart Association states that women are less likely than men to receive guideline-directed treatment after heart attack or unstable angina, including timely revascularization procedures such as bypass surgery or stent placement. [https://www.heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women](https://www.heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women)

• The claim is stated broadly, but treatment differences do not necessarily prove discriminatory withholding. Women and men can have biologically different disease mechanisms, contraindications, disease severity, anatomy, risks, or treatment indications. For example, the American Heart Association notes that women more often have heart attacks caused by plaque erosion, spontaneous coronary artery dissection, or mechanisms other than a blocked artery; these conditions may not be treated with stents in the same way as typical obstructive disease. [https://www.heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women](https://www.heart.org/en/news/2024/02/09/the-slowly-evolving-truth-about-heart-disease-and-women)
• Not every study finds a female disadvantage. A 2021 hospital emergency-department study of opioid prescribing reported no bias toward women. [https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-11551-9](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-11551-9)
• An earlier multicenter emergency-department study found no statistically significant overall difference in analgesic administration by patient sex: analgesics were given to 63% of female patients and 57% of male patients. It did, however, find interactions involving physician and patient sex, so it does not establish that treatment is always equal. [https://academic.oup.com/painmedicine/article/10/2/364/1833196](https://academic.oup.com/painmedicine/article/10/2/364/1833196)
• The wording says women with the same medical condition are less likely to be offered treatment in general. The strongest evidence is condition-specific—especially acute pain and some forms of acute coronary disease—and cannot automatically be generalized to every medical condition, every surgery, every stent decision, or every strong painkiller.

88/100 — the lab’s own confidence in the score above, not a second reading of the claim.

University of St Andrewsedu · 86 · Proceedings of the National Academy of Sciencesjournal · 94 · Academic Emergency Medicinejournal · 93 · American Heart Associationother · 91 · BBC Newsnews · 89 · BMC Public Healthjournal · 91 · Pain Medicinejournal · 90

• Multiple large observational studies and registries show women with acute coronary syndromes receive coronary angiography, PCI/stents and CABG at lower rates than men with comparable indications and anatomy.
• Emergency-department studies find women with similar pain scores and diagnoses are less often given opioid analgesics than men.
• The pattern is long-recognized in cardiology as the Yentl syndrome and has been replicated across countries and decades for several conditions including ischemic heart disease.

• Gaps often shrink after adjustment for age (women present older), delayed/atypical presentation, comorbidities and angiographic complexity, indicating case-mix explains part of the raw difference.
• Women have smaller coronary arteries on average, raising technical difficulty and complication risk for stenting and thereby providing a non-bias clinical reason for different procedure rates.
• Disparities are not uniform across all conditions, health systems or recent years; some contemporary high-income registries show narrowing or disappearance of gaps for guideline therapies.
• Patient preference, treatment refusal and differing symptom reporting also contribute independently of physician bias.

82/100 — the lab’s own confidence in the score above, not a second reading of the claim.

New England Journal of Medicinejournal · 98 · CDCgov · 92 · Circulation (AHA)journal · 95 · Academic Emergency Medicine / PubMedjournal · 88